Skip to main content
Livermore
Livermore
ZHEN

Man Group plc

SEC CIK
0001637460
Latest filing
Aug 14, 2026

CPRX holding history

Catalyst Pharmaceuticals, Inc. in every 13F filed by Man Group plc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CPRX overviewAll 13F holders of CPRXFull Q2 2026 holdings

Shares (Q2 2026)
250,000
Value
$7.86M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of CPRX by Man Group plc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026250,000$7.86M<0.1%+164,162+191.2%AddedHolders
Q1 202685,838$2.13M<0.1%−102,946−54.5%ReducedHolders
Q4 2025188,784$4.41M<0.1%−275,218−59.3%ReducedHolders
Q3 2025464,002$9.14M<0.1%+33,098+7.7%AddedHolders
Q2 2025430,904$9.35M<0.1%+135,162+45.7%AddedHolders
Q1 2025295,742$7.17M<0.1%−20,075−6.4%ReducedHolders
Q4 2024315,817$6.59M<0.1%+61,123+24.0%AddedHolders
Q3 2024254,694$5.06M<0.1%−215,150−45.8%ReducedHolders
Q2 2024469,844$7.28M<0.1%−149,567−24.1%ReducedHolders
Q1 2024619,411$9.87M<0.1%−24,805−3.9%ReducedHolders
Q4 2023644,216$10.8M<0.1%––Holders
Q3 2023–$7.94M<0.1%––Holders
Q2 2023835,008$11.2M<0.1%––Holders
Q1 2023–$14.9M0.1%––Holders
Q4 2022889,532$16.5M0.1%+102,432+13.0%AddedHolders
Q3 2022787,100$10.1M<0.1%––Holders
Q2 2022–$2.14M<0.1%––Holders
Q1 2022256,100$2.12M<0.1%−136,800−34.8%ReducedHolders
Q4 2021392,900$2.66M<0.1%+87,000+28.4%AddedHolders
Q3 2021305,900$1.62M<0.1%00.0%UnchangedHolders
Q2 2021305,900$1.76M<0.1%−58,327−16.0%ReducedHolders
Q1 2021364,227$1.68M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.